We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Pharmacovigilance – Products

Sygnature Discovery logo.
Product News

Sygnature Discovery Launches Its LPS In Vivo Model To Profile Early-Stage Anti-Inflammatory Drugs

Sygnature Discovery has established an in vivo LPS model of inflammation which can help understand life-limiting neuroinflammatory conditions like Parkinson’s disease, multiple sclerosis, Alzheimer’s disease, and traumatic brain injuries and identify new drug targets.
The Avacta logo
Product News

Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase I Clinical Study

Avacta Group plc has announced that the fifth dose escalation cohort in the ALS-6000-101 dose escalation Phase 1 clinical trial to evaluate the safety and tolerability of AVA6000 has been completed successfully.
organoid
App Note / Case Study

Optimizing Organoid Culture Conditions

This application note outlines the importance of reagent consistency in organoid tissue culture.
The Signals Research Suite software.
Product News

Revvity Launches First Scientific SaaS Platform to Accelerate Drug and Materials Development

Revvity, Inc announced the launch of its Signals Research Suite, a unified, cloud-native SaaS platform that drives scientific collaboration across R&D disciplines from drug discovery to specialty chemicals material development.
Remegen logo.
Product News

ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer

RemeGen Co., Ltd announced the latest clinical research results on disitamab vedotin at this year's American Society of Clinical Oncology Annual Meeting.
The Samsara therapeutics logo
Product News

Samsara Therapeutics Unveils Promising Autophagy Drug Candidate

Samsara Therapeutics has announced the company’s autophagy-inducing candidate SAM001, the first agent of its class to enter clinical trials.
Gyrolab® Generic Cyno ADA Kit Reagents
Product News

Gyros Protein Technologies Introduces Gyrolab Generic Cyno ADA Kit Reagents

Gyros Protein Technologies AB has announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.
White pills on a yellow background
Product News

Pharmacogenomics Research Could Save NHS at Least £41 Million Annually

An analysis of NHS prescriptions data has revealed the huge potential for pharmacogenomics to reduce ineffective prescribing and adverse effects, which could save millions of pounds for the NHS.
One - Stop Research Support for CAR - NK Therapy content piece image
Product
Advertisement

One - Stop Research Support for CAR - NK Therapy

CARNK cell therapies are novel therapeutic options developed with the aim to overcome some limitations of CART cell therapies, such as therapy induced side effects.
The Avacta logo.
Product News

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

Avacta Group plc announces the opening of the first two clinical investigator sites for the phase 1 clinical trial of AVA6000 under its US Investigational New Drug Application.
Advertisement